يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Rahel Frölich"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

    المؤلفون: Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita M. Dreyer, Robert W. Kaminski, Chad K. Porter, Subhra Chakraborty, Kristen A. Clarkson, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey Weerts, Brittany L. Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck

    المصدر: EBioMedicine, Vol 66, Iss , Pp 103310- (2021)

    مصطلحات موضوعية: Shigella, Shigella flexneri 2a, Vaccine, Bioconjugate vaccine, Controlled human challenge study, Medicine, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2352396421001031; https://doaj.org/toc/2352-3964

    URL الوصول: https://doaj.org/article/1410f37230014cc3bbc215ab53fb2558

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

    المؤلفون: Kristen A. Clarkson, Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita Dreyer, Chad K. Porter, Subhra Chakraborty, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey P. Weerts, Brittany Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck, Robert W. Kaminski

    المصدر: EBioMedicine, Vol 66, Iss , Pp 103308- (2021)

    مصطلحات موضوعية: Shigella, Immunogenicity, Bioconjugate vaccine, Human challenge, Gut-homing responses, Parenteral immunization, Medicine, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2352396421001018; https://doaj.org/toc/2352-3964

    URL الوصول: https://doaj.org/article/cce33f902cd64e25ad5106ca4d7aa302

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  3. 3
    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

    المؤلفون: Subhra Chakraborty, Hailey P. Weerts, Robert W. Kaminski, Jessica Brubaker, Kawsar R. Talaat, Kristen A. Clarkson, Patricia Martin, A. Louis Bourgeois, Rahel Frölich, Jane Halpern, Mark S. Riddle, Anita M. Dreyer, Barbara DeNearing, Veronica Gambillara Fonck, David A. Sack, Cristina Alaimo, Daniel Elwood, Brittany Feijoo, Chad K. Porter

    المصدر: EBioMedicine
    EBioMedicine, Vol 66, Iss, Pp 103308-(2021)

    مصطلحات موضوعية: 0301 basic medicine, Shigellosis, Medicine (General), Gut-homing responses, medicine.disease_cause, Parenteral immunization, Human challenge, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Immune system, Shigella flexneri, R5-920, Medicine, Shigella, Shigella vaccine, biology, business.industry, Immunogenicity, General Medicine, medicine.disease, biology.organism_classification, Vaccination, 030104 developmental biology, Bioconjugate vaccine, Immunization, 030220 oncology & carcinogenesis, Immunology, business, Research Paper

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c4cbb1bae4df9ab9d84eb1fbda34300
    http://europepmc.org/articles/PMC8047506

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  4. 4
    Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

    المؤلفون: Darren Abbanat, Enos Bernasconi, Stéphan Juergen Harbarth, Ingrid van den Nieuwenhof, Anette Kuhn, P. Martín, Serge de Vallière, Stefan Thoelen, Rahel Frölich, Germie van den Dobbelsteen, Todd A. Davies, Christoph Hatz, Tanja Hülder, Angela Huttner, Anita M. Dreyer, Volker Viereck, Veronica Gambillara Fonck, Gloria Ryu, Kerstin Kling, Sabine Gröger, Jan Poolman, Cristina Alaimo, Alena Hornacek, David Scheiner, Kellen Fae, Tilemachos Kavvadias

    المصدر: The Lancet Infectious Diseases, Vol. 17, No 5 (2017) pp. 528-537

    مصطلحات موضوعية: Adult, 0301 basic medicine, Serotype, medicine.medical_specialty, Extraintestinal Pathogenic Escherichia coli, Urinary Tract Infections/prevention & control, Placebo, Escherichia coli Vaccines/administration & dosage/therapeutic use, law.invention, 03 medical and health sciences, Immunogenicity, Vaccine, Randomized controlled trial, law, Internal medicine, medicine, Humans, Single-Blind Method, Vaccination/methods, 610 Medicine & health, Adverse effect, Aged, ddc:616, Escherichia coli Vaccines, business.industry, Immunogenicity, Incidence (epidemiology), Vaccination, Middle Aged, Extraintestinal Pathogenic Escherichia coli/isolation & purification, Treatment Outcome, 030104 developmental biology, Infectious Diseases, Urinary Tract Infections, Immunology, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b08576980adde2c05ab333e1587296
    https://doi.org/10.1016/s1473-3099(17)30108-1

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء